Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Phospho serine and threonine analysis of normal and mutated granulocyte colony stimulating factor receptors.

Dwivedi P, Muench DE, Wagner M, Azam M, Grimes HL, Greis KD.

Sci Data. 2019 Apr 9;6(1):21. doi: 10.1038/s41597-019-0015-8.

2.

Identification of Urinary CD44 and Prosaposin as Specific Biomarkers of Urinary Tract Infections in Children With Neurogenic Bladders.

Forster CS, Haffey WD, Bennett M, Greis KD, Devarajan P.

Biomark Insights. 2019 Mar 15;14:1177271919835570. doi: 10.1177/1177271919835570. eCollection 2019.

3.

Utilization of Reactive Oxygen Species Targeted Therapy to Prolong the Efficacy of BRAF Inhibitors in Melanoma.

Yuan L, Mishra R, Patel H, Abdulsalam S, Greis KD, Kadekaro AL, Merino EJ, Garrett JT.

J Cancer. 2018 Nov 24;9(24):4665-4676. doi: 10.7150/jca.27295. eCollection 2018.

4.

Domain unfolding of monoclonal antibody fragments revealed by non-reducing SDS-PAGE.

Kirley TL, Greis KD, Norman AB.

Biochem Biophys Rep. 2018 Oct 31;16:138-144. doi: 10.1016/j.bbrep.2018.10.004. eCollection 2018 Dec.

5.

Multiplex Biomarker Screening Assay for Urinary Extracellular Vesicles Study: A Targeted Label-Free Proteomic Approach.

Chutipongtanate S, Greis KD.

Sci Rep. 2018 Oct 9;8(1):15039. doi: 10.1038/s41598-018-33280-7.

6.

Discovery of SERPINA3 as a candidate urinary biomarker of lupus nephritis activity.

Turnier JL, Brunner HI, Bennett M, Aleed A, Gulati G, Haffey WD, Thornton S, Wagner M, Devarajan P, Witte D, Greis KD, Aronow B.

Rheumatology (Oxford). 2019 Feb 1;58(2):321-330. doi: 10.1093/rheumatology/key301.

PMID:
30285245
7.

Time resolved quantitative phospho-tyrosine analysis reveals Bruton's Tyrosine kinase mediated signaling downstream of the mutated granulocyte-colony stimulating factor receptors.

Dwivedi P, Muench DE, Wagner M, Azam M, Grimes HL, Greis KD.

Leukemia. 2019 Jan;33(1):75-87. doi: 10.1038/s41375-018-0188-8. Epub 2018 Jul 5.

8.

Author Correction: Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation.

Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, Zhao BS, Mesquita A, Liu C, Yuan CL, Hu YC, Hüttelmaier S, Skibbe JR, Su R, Deng X, Dong L, Sun M, Li C, Nachtergaele S, Wang Y, Hu C, Ferchen K, Greis KD, Jiang X, Wei M, Qu L, Guan JL, He C, Yang J, Chen J.

Nat Cell Biol. 2018 Sep;20(9):1098. doi: 10.1038/s41556-018-0102-7.

PMID:
29880862
9.

Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation.

Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, Zhao BS, Mesquita A, Liu C, Yuan CL, Hu YC, Hüttelmaier S, Skibbe JR, Su R, Deng X, Dong L, Sun M, Li C, Nachtergaele S, Wang Y, Hu C, Ferchen K, Greis KD, Jiang X, Wei M, Qu L, Guan JL, He C, Yang J, Chen J.

Nat Cell Biol. 2018 Mar;20(3):285-295. doi: 10.1038/s41556-018-0045-z. Epub 2018 Feb 23. Erratum in: Nat Cell Biol. 2018 Sep;20(9):1098.

10.

The nuclear DEK interactome supports multi-functionality.

Smith EA, Krumpelbeck EF, Jegga AG, Prell M, Matrka MM, Kappes F, Greis KD, Ali AM, Meetei AR, Wells SI.

Proteins. 2018 Jan;86(1):88-97. doi: 10.1002/prot.25411. Epub 2017 Nov 11.

11.

A Novel Biomarker Panel to Identify Steroid Resistance in Childhood Idiopathic Nephrotic Syndrome.

Bennett MR, Pleasant L, Haffner C, Ma Q, Haffey WD, Ying J, Wagner M, Greis KD, Devarajan P.

Biomark Insights. 2017 Mar 8;12:1177271917695832. doi: 10.1177/1177271917695832. eCollection 2017.

12.

Corrigendum: Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia.

Fang J, Bolanos LC, Choi K, Liu X, Christie S, Akunuru S, Kumar R, Wang D, Chen X, Greis KD, Stoilov P, Filippi MD, Maciejewski JP, Garcia-Manero G, Weirauch MT, Salamonis N, Geiger H, Zheng Y, Starczynowski DT.

Nat Immunol. 2017 Mar 22;18(4):474. doi: 10.1038/ni0417-474a. No abstract available.

13.

Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia.

Fang J, Bolanos LC, Choi K, Liu X, Christie S, Akunuru S, Kumar R, Wang D, Chen X, Greis KD, Stoilov P, Filippi MD, Maciejewski JP, Garcia-Manero G, Weirauch MT, Salomonis N, Geiger H, Zheng Y, Starczynowski DT.

Nat Immunol. 2017 Feb;18(2):236-245. doi: 10.1038/ni.3654. Epub 2016 Dec 26. Erratum in: Nat Immunol. 2017 Mar 22;18(4):474.

14.

Selective disulfide reduction for labeling and enhancement of Fab antibody fragments.

Kirley TL, Greis KD, Norman AB.

Biochem Biophys Res Commun. 2016 Nov 25;480(4):752-757. doi: 10.1016/j.bbrc.2016.10.128. Epub 2016 Oct 29.

15.

Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies.

Dwivedi P, Greis KD.

Exp Hematol. 2017 Feb;46:9-20. doi: 10.1016/j.exphem.2016.10.008. Epub 2016 Oct 24. Review.

16.

Structural characterization of expressed monoclonal antibodies by single sample mass spectral analysis after IdeS proteolysis.

Kirley TL, Greis KD, Norman AB.

Biochem Biophys Res Commun. 2016 Aug 26;477(3):363-8. doi: 10.1016/j.bbrc.2016.06.099. Epub 2016 Jun 21.

17.

Effects of Bacterial Community Members on the Proteome of the Ammonia-Oxidizing Bacterium Nitrosomonas sp. Strain Is79.

Sedlacek CJ, Nielsen S, Greis KD, Haffey WD, Revsbech NP, Ticak T, Laanbroek HJ, Bollmann A.

Appl Environ Microbiol. 2016 Jul 15;82(15):4776-4788. doi: 10.1128/AEM.01171-16. Print 2016 Aug 1.

18.

Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles.

Blanco VM, Chu Z, LaSance K, Gray BD, Pak KY, Rider T, Greis KD, Qi X.

Oncotarget. 2016 May 31;7(22):32866-75. doi: 10.18632/oncotarget.8763.

19.

Systematic evaluation of data-independent acquisition for sensitive and reproducible proteomics-a prototype design for a single injection assay.

Heaven MR, Funk AJ, Cobbs AL, Haffey WD, Norris JL, McCullumsmith RE, Greis KD.

J Mass Spectrom. 2016 Jan;51(1):1-11. doi: 10.1002/jms.3716.

20.

A ROS-Activatable Agent Elicits Homologous Recombination DNA Repair and Synergizes with Pathway Compounds.

Thowfeik FS, AbdulSalam SF, Wunderlich M, Wyder M, Greis KD, Kadekaro AL, Mulloy JC, Merino EJ.

Chembiochem. 2015 Nov;16(17):2513-21. doi: 10.1002/cbic.201500304. Epub 2015 Nov 2.

21.

Cardiac metabolic pathways affected in the mouse model of barth syndrome.

Huang Y, Powers C, Madala SK, Greis KD, Haffey WD, Towbin JA, Purevjav E, Javadov S, Strauss AW, Khuchua Z.

PLoS One. 2015 Jun 1;10(6):e0128561. doi: 10.1371/journal.pone.0128561. eCollection 2015.

22.

Phosphopeptide separation using radially aligned titania nanotubes on titanium wire.

Wijeratne AB, Wijesundera DN, Paulose M, Ahiabu IB, Chu WK, Varghese OK, Greis KD.

ACS Appl Mater Interfaces. 2015 Jun 3;7(21):11155-64. doi: 10.1021/acsami.5b00799. Epub 2015 May 18.

PMID:
25941752
23.

Advanced hair damage model from ultra-violet radiation in the presence of copper.

Marsh JM, Davis MG, Flagler MJ, Sun Y, Chaudhary T, Mamak M, McComb DW, Williams RE, Greis KD, Rubio L, Coderch L.

Int J Cosmet Sci. 2015 Oct;37(5):532-41. doi: 10.1111/ics.12231. Epub 2015 Jun 9.

PMID:
25923177
24.

Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression.

Lu X, Zoller EE, Weirauch MT, Wu Z, Namjou B, Williams AH, Ziegler JT, Comeau ME, Marion MC, Glenn SB, Adler A, Shen N, Nath SK, Stevens AM, Freedman BI, Tsao BP, Jacob CO, Kamen DL, Brown EE, Gilkeson GS, Alarcón GS, Reveille JD, Anaya JM, James JA, Sivils KL, Criswell LA, Vilá LM, Alarcón-Riquelme ME, Petri M, Scofield RH, Kimberly RP, Ramsey-Goldman R, Joo YB, Choi J, Bae SC, Boackle SA, Graham DC, Vyse TJ, Guthridge JM, Gaffney PM, Langefeld CD, Kelly JA, Greis KD, Kaufman KM, Harley JB, Kottyan LC.

Am J Hum Genet. 2015 May 7;96(5):731-9. doi: 10.1016/j.ajhg.2015.03.002. Epub 2015 Apr 9.

25.

SCML2 establishes the male germline epigenome through regulation of histone H2A ubiquitination.

Hasegawa K, Sin HS, Maezawa S, Broering TJ, Kartashov AV, Alavattam KG, Ichijima Y, Zhang F, Bacon WC, Greis KD, Andreassen PR, Barski A, Namekawa SH.

Dev Cell. 2015 Mar 9;32(5):574-88. doi: 10.1016/j.devcel.2015.01.014. Epub 2015 Feb 19.

26.

The LIMP-2/SCARB2 binding motif on acid β-glucosidase: basic and applied implications for Gaucher disease and associated neurodegenerative diseases.

Liou B, Haffey WD, Greis KD, Grabowski GA.

J Biol Chem. 2014 Oct 24;289(43):30063-74. doi: 10.1074/jbc.M114.593616. Epub 2014 Sep 8.

27.

Quantitative phosphoproteomics using acetone-based peptide labeling: method evaluation and application to a cardiac ischemia/reperfusion model.

Wijeratne AB, Manning JR, Schultz Jel J, Greis KD.

J Proteome Res. 2013 Oct 4;12(10):4268-79. doi: 10.1021/pr400835k. Epub 2013 Sep 24.

28.

Role of copper in photochemical damage to hair.

Marsh JM, Iveson R, Flagler MJ, Davis MG, Newland AB, Greis KD, Sun Y, Chaudhary T, Aistrup ER.

Int J Cosmet Sci. 2014 Feb;36(1):32-8. doi: 10.1111/ics.12088. Epub 2013 Oct 10.

PMID:
23962007
29.

Heparin-binding motifs and biofilm formation by Candida albicans.

Green JV, Orsborn KI, Zhang M, Tan QK, Greis KD, Porollo A, Andes DR, Long Lu J, Hostetter MK.

J Infect Dis. 2013 Nov 15;208(10):1695-704. doi: 10.1093/infdis/jit391. Epub 2013 Jul 31.

30.

Members of the DAN family are BMP antagonists that form highly stable noncovalent dimers.

Kattamuri C, Luedeke DM, Nolan K, Rankin SA, Greis KD, Zorn AM, Thompson TB.

J Mol Biol. 2012 Dec 14;424(5):313-27. doi: 10.1016/j.jmb.2012.10.003. Epub 2012 Oct 9.

31.

Apolipoprotein A-II-mediated conformational changes of apolipoprotein A-I in discoidal high density lipoproteins.

Gauthamadasa K, Vaitinadin NS, Dressman JL, Macha S, Homan R, Greis KD, Silva RA.

J Biol Chem. 2012 Mar 2;287(10):7615-25. doi: 10.1074/jbc.M111.291070. Epub 2012 Jan 10.

32.

Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction.

Govindan S, McElligott A, Muthusamy S, Nair N, Barefield D, Martin JL, Gongora E, Greis KD, Luther PK, Winegrad S, Henderson KK, Sadayappan S.

J Mol Cell Cardiol. 2012 Jan;52(1):154-64. doi: 10.1016/j.yjmcc.2011.09.011. Epub 2011 Sep 19.

33.

The synthesis and evaluation of indolylureas as PKCα inhibitors.

Djung JF, Mears RJ, Montalbetti CA, Coulter TS, Golebiowski A, Carr AN, Barker O, Greis KD, Zhou S, Dolan E, Davis GF.

Bioorg Med Chem. 2011 Apr 15;19(8):2742-50. doi: 10.1016/j.bmc.2011.02.036. Epub 2011 Feb 26.

PMID:
21435888
34.

Absence of polo-like kinase 3 in mice stabilizes Cdc25A after DNA damage but is not sufficient to produce tumors.

Myer DL, Robbins SB, Yin M, Boivin GP, Liu Y, Greis KD, Bahassi el M, Stambrook PJ.

Mutat Res. 2011 Sep 1;714(1-2):1-10. doi: 10.1016/j.mrfmmm.2011.02.006. Epub 2011 Mar 3.

PMID:
21376736
35.

Comparative proteomic analysis of lung lamellar bodies and lysosome-related organelles.

Ridsdale R, Na CL, Xu Y, Greis KD, Weaver T.

PLoS One. 2011 Jan 26;6(1):e16482. doi: 10.1371/journal.pone.0016482.

36.

Multiplex enzyme assays and inhibitor screening by mass spectrometry.

Rathore R, Pribil P, Corr JJ, Seibel WL, Evdokimov A, Greis KD.

J Biomol Screen. 2010 Sep;15(8):1001-7. doi: 10.1177/1087057110363824. Epub 2010 Mar 12.

PMID:
20228278
37.

Extending matrix-assisted laser desorption/ionization triple quadrupole mass spectrometry enzyme screening assays to targets with small molecule substrates.

Rathore R, Corr JJ, Lebre DT, Seibel WL, Greis KD.

Rapid Commun Mass Spectrom. 2009 Oct 30;23(20):3293-300. doi: 10.1002/rcm.4248.

PMID:
19757451
38.

Akt and 14-3-3 control a PACS-2 homeostatic switch that integrates membrane traffic with TRAIL-induced apoptosis.

Aslan JE, You H, Williamson DM, Endig J, Youker RT, Thomas L, Shu H, Du Y, Milewski RL, Brush MH, Possemato A, Sprott K, Fu H, Greis KD, Runckel DN, Vogel A, Thomas G.

Mol Cell. 2009 May 14;34(4):497-509. doi: 10.1016/j.molcel.2009.04.011.

39.

Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis.

Suzuki M, Wiers K, Brooks EB, Greis KD, Haines K, Klein-Gitelman MS, Olson J, Onel K, O'Neil KM, Silverman ED, Tucker L, Ying J, Devarajan P, Brunner HI.

Pediatr Res. 2009 May;65(5):530-6. doi: 10.1203/PDR.0b013e31819e4305.

40.

iTRAQ proteomic identification of pVHL-dependent and -independent targets of Egln1 prolyl hydroxylase knockdown in renal carcinoma cells.

Haffey WD, Mikhaylova O, Meller J, Yi Y, Greis KD, Czyzyk-Krzeska MF.

Adv Enzyme Regul. 2009;49(1):121-32. doi: 10.1016/j.advenzreg.2008.12.004. Epub 2008 Dec 31. No abstract available.

41.

Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice.

Eismann T, Huber N, Shin T, Kuboki S, Galloway E, Wyder M, Edwards MJ, Greis KD, Shertzer HG, Fisher AB, Lentsch AB.

Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G266-74. doi: 10.1152/ajpgi.90583.2008. Epub 2008 Nov 25.

42.

Development of an inhibitor screening platform via mass spectrometry.

Rathore R, Corr J, Scott G, Vollmerhaus P, Greis KD.

J Biomol Screen. 2008 Dec;13(10):1007-13. doi: 10.1177/1087057108326143. Epub 2008 Nov 21.

PMID:
19029013
43.

The von Hippel-Lindau tumor suppressor protein and Egl-9-Type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress.

Mikhaylova O, Ignacak ML, Barankiewicz TJ, Harbaugh SV, Yi Y, Maxwell PH, Schneider M, Van Geyte K, Carmeliet P, Revelo MP, Wyder M, Greis KD, Meller J, Czyzyk-Krzeska MF.

Mol Cell Biol. 2008 Apr;28(8):2701-17. doi: 10.1128/MCB.01231-07. Epub 2008 Feb 19.

44.
45.

MALDI-TOF MS as a label-free approach to rapid inhibitor screening.

Greis KD, Zhou S, Burt TM, Carr AN, Dolan E, Easwaran V, Evdokimov A, Kawamoto R, Roesgen J, Davis GF.

J Am Soc Mass Spectrom. 2006 Jun;17(6):815-822. doi: 10.1016/j.jasms.2006.02.019. Epub 2006 Apr 17.

46.

Development and validation of a whole-cell inhibition assay for bacterial methionine aminopeptidase by surface-enhanced laser desorption ionization-time of flight mass spectrometry.

Greis KD, Zhou S, Siehnel R, Klanke C, Curnow A, Howard J, Layh-Schmitt G.

Antimicrob Agents Chemother. 2005 Aug;49(8):3428-34.

47.

Proteome analysis of the rat cornea during angiogenesis.

Thompson LJ, Wang F, Proia AD, Peters KG, Jarrold B, Greis KD.

Proteomics. 2003 Nov;3(11):2258-66.

PMID:
14595824
48.

Mechanism of insulin sensitization by BMOV (bis maltolato oxo vanadium); unliganded vanadium (VO4) as the active component.

Peters KG, Davis MG, Howard BW, Pokross M, Rastogi V, Diven C, Greis KD, Eby-Wilkens E, Maier M, Evdokimov A, Soper S, Genbauffe F.

J Inorg Biochem. 2003 Aug 1;96(2-3):321-30.

PMID:
12888267
50.

Proteomic analysis of rat soleus and tibialis anterior muscle following immobilization.

Isfort RJ, Wang F, Greis KD, Sun Y, Keough TW, Bodine SC, Anderson NL.

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Apr 5;769(2):323-32.

PMID:
11996498

Supplemental Content

Loading ...
Support Center